1. Home
  2. HIHO vs INAB Comparison

HIHO vs INAB Comparison

Compare HIHO & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIHO
  • INAB
  • Stock Information
  • Founded
  • HIHO 1990
  • INAB 2016
  • Country
  • HIHO Hong Kong
  • INAB United States
  • Employees
  • HIHO N/A
  • INAB N/A
  • Industry
  • HIHO Industrial Machinery/Components
  • INAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIHO Industrials
  • INAB Health Care
  • Exchange
  • HIHO Nasdaq
  • INAB Nasdaq
  • Market Cap
  • HIHO 7.6M
  • INAB 7.5M
  • IPO Year
  • HIHO 1996
  • INAB 2021
  • Fundamental
  • Price
  • HIHO $1.63
  • INAB $2.25
  • Analyst Decision
  • HIHO
  • INAB Strong Buy
  • Analyst Count
  • HIHO 0
  • INAB 2
  • Target Price
  • HIHO N/A
  • INAB $108.00
  • AVG Volume (30 Days)
  • HIHO 5.9K
  • INAB 119.6K
  • Earning Date
  • HIHO 10-09-2025
  • INAB 08-07-2025
  • Dividend Yield
  • HIHO 7.45%
  • INAB N/A
  • EPS Growth
  • HIHO N/A
  • INAB N/A
  • EPS
  • HIHO 0.02
  • INAB N/A
  • Revenue
  • HIHO $7,412,000.00
  • INAB N/A
  • Revenue This Year
  • HIHO N/A
  • INAB N/A
  • Revenue Next Year
  • HIHO N/A
  • INAB N/A
  • P/E Ratio
  • HIHO $81.00
  • INAB N/A
  • Revenue Growth
  • HIHO 17.26
  • INAB N/A
  • 52 Week Low
  • HIHO $1.39
  • INAB $1.98
  • 52 Week High
  • HIHO $2.88
  • INAB $21.21
  • Technical
  • Relative Strength Index (RSI)
  • HIHO 47.30
  • INAB 47.06
  • Support Level
  • HIHO $1.57
  • INAB $2.01
  • Resistance Level
  • HIHO $1.64
  • INAB $2.38
  • Average True Range (ATR)
  • HIHO 0.04
  • INAB 0.14
  • MACD
  • HIHO -0.00
  • INAB 0.03
  • Stochastic Oscillator
  • HIHO 46.15
  • INAB 45.76

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: